Trinity Biotech to Present at Emerging Growth Conference
08 Fevereiro 2024 - 10:30AM
Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), today announces
that management will present virtually at the Emerging Growth
Conference on March 7, 2024. The Company invites individual and
institutional investors as well as advisors and analysts, to attend
its real-time, interactive presentation at the Emerging Growth
Conference. Please see the presentation information below.
Presentation Details
Date: |
Thursday, March 7, 2024 |
Time: |
11:25 – 11:55 AM ET |
Registration: |
https://goto.webcasts.com/starthere.jsp?ei=1650531&tp_key=ca9510e531&sti=trib |
About Trinity Biotech Plc
Trinity Biotech develops, acquires, manufactures
and markets diagnostic systems, including both reagents and
instrumentation, for the point-of-care and clinical laboratory
segments of the diagnostic market. The products are used to detect
infectious diseases and to quantify the level of Haemoglobin A1c
and other chemistry parameters in serum, plasma and whole blood.
Trinity Biotech sells direct in the United States, Germany, France
and the U.K. and through a network of international distributors
and strategic partners in over 75 countries worldwide. For further
information, please see the Company's website:
www.trinitybiotech.com
Contact: |
Trinity Biotech plcDes
Fitzgerald(353)-1-2769800 |
LifeSci Partners, LLCEric
Ribner(1)-646-751-4363E-mail investorrelations@trinitybiotech.com |
Trinity Biotech (NASDAQ:TRIB)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Trinity Biotech (NASDAQ:TRIB)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024